Cellulite Treatment in Vienna AT
Cellulite Treatment
Cellulite is a skin condition commonly situated in the hips, thighs and buttocks. It has a cottage cheese appearance and multiple dimples on the skin. It is not related to being overweight but is genetic.
Cellulite treatment is not a surgical procedure. Treatment does not break the skin. It is a safe non-surgical approach to body contouring.
Best candidates are men and women who are in good health, have good skin tone and have realistic expectations. The results will produce an improvement in skin tone, the appearance of stretchmarks, and loose skin may be improved.
It is recommended to add diet and exercise to daily routine while undergoing cellulite treatments.
The cellulite treatment called Mesotherapy is considered very effective. The cellulite area develops increased blood flow and lymphatic flow, decreased fibrosis of the connective tissue and reduction of fat deposits. The result is smooth skin and cellulite reduction. This type of cellulite treatment uses a mixture of substances including vitamins, herbs and other homeopathic medications. This treatment is custom-tailored for each individual. Very short and thin needles re used to inject the formulations.
When treating cellulite, one formulation of medications may be used to dissolve fat, and another to destroy fibrous bands that bind the skin. This treatment is virtually painless. One can return to normal activities immediately.
The risks involved in this treatment are the possibility of allergic reaction to the mesotherapy solution. Since a needle is used, there is a possibility of infection at the site of injections. Mild or minor bruising at injection site is also a possibility. There may also be some itching after the treatment.
This procedure is performed in a medical setting. The patient does not need anesthesia. No post-operative recovery time. For those with sensitive skin, an anesthetic cream can be applied 1/2 hour before the treatment.
Another cellulite treatment is Lipodissolve. This is also a non-surgical procedure. This cellulite treatment involves the injection of phosphatidylcholine (PPC) into small fat deposits to dissolve fat. PPC is a natural enzyme. This compound is injected into the fat through multiple microinjections. The treatment is to dissolve fat which is removed through normal waste removal. It is virtually painless. No heavy bandages and one can resume work with no down time.
The procedure takes 30-60 minutes depending on areas treated. The patient can return to normal activities after the procedure.
The risks involved are the same as the above treatment. Plus the patient might feel light-headedness or slight nausea. This should pass quickly. The area treated will be swollen and tender for a few days and up to a few weeks.
SmartLipo, also known as laser liposuction is the latest fat removal treatment. This procedure involves the use of a laser that dissolves the fat and tightens the surrounding skin. This treatment is done in an office and does not require general anesthetic. The doctor will mark the targeted areas and local anesthetic is given. A small tube containing a laser is inserted into the skin. The laser's energy causes the fat cells to rupture and drain away. This is removed by the body's waste system. With this cellulite treatment, there is less bleeding and swelling. This causes the skin to tighten and shrink gradually in about 6-8 weeks.
The risks involved in this procedure are mild swelling, bruising or tenderness at site of insertion. There is rarely infection and a possibility of haematoma (collection of blood underneath the skin) following treatment. Asymmetrical results and minor scarring can be long term risks.
Best results are seen after 2 months. Downtime is minimal. The patient can return to work within 24 hours.
More Vienna info...
Vienna Budget
Cafe Restaurant Kent, Brunnengasse 67, A-1160 Wien. "Eat like the locals - eat Turkish!" At first approach this looks like a greasy kebab joint strictly for Turks... but struggle past the first room and you will find a large garden and huge restaurant serving moderately priced food with an infinite supply of free Turkish bread! Expect to pay under 10 euros. Good for veggies and meat eaters alike. Also try the turkish breakfast.
Kolar [42] - nice Pubs/Beisls. They have a tasty "Fladenbrot". Laudongasse 8, 1080 Wien. -
Vienna Fast Food and Snacks
The traditional Viennese fast food is sausage. You can buy hot sausages and hot dogs at snack bars called "W?rstelstand" all over the town. The famous Wiener W?rstel is also known as the Frankfurter in Vienna, but most inhabitants prefer Burenwurst and K?sekrainer (sausage filled with cheese).
A relatively new addition to the local snack culture is D?ner Kebap, sandwiches of Turkish origin with roasted meat, salad and yogurt sauce. Places that sell kebap often sell take-away pizza too. Some conservatives are afraid that kebap will gain more popularity than sausages, and perhaps they are right.
Good kebaps can be bought at the Naschmarkt; the lower end of the Naschmarkt (furthest away from Karlsplatz or city centre) is cheaper than the upper end. Another good place to find snacks (especialy whilegoing out) is "Schwedenplatz".
-Plastic Surgery News...
- A leading UK charity has published the results of a survey that shows the number of GPs prescribing exercise as a treatment for depression has gone up in the last three years.The Mental Health Foundation announced to the press today, Friday 8th February, that it found 22 per cent of GPs now prescribe exercise as one of the three preferred treatments for depression.
Context Gene expression profiling may be useful for prognostic and therapeutic strategies in breast carcinoma.
Objectives To demonstrate the value in integrating genomic information with clinical and pathological risk factors, to refine prognosis, and to improve therapeutic strategies for early stage breast cancer.
Design, Setting, and Patients Retrospective study of patients with early stage breast carcinoma who were candidates for adjuvant chemotherapy; 964 clinically annotated breast tumor samples (573 in the initial discovery set and 391 in the validation cohort) with corresponding microarray data were used. All patients were assigned relapse risk scores based on their respective clinicopathological features. Signatures representing oncogenic pathway activation and tumor biology/microenvironment status were applied to these samples to obtain patterns of deregulation that correspond with relapse risk scores to refine prognosis with the clinicopathological prognostic model alone. Predictors of chemotherapeutic response were also applied to further characterize clinically relevant heterogeneity in early stage breast cancer.
Main Outcome Measures Gene expression signatures and clinicopathological variables in early stage breast cancer to determine a refined estimation of relapse-free survival and sensitivity to chemotherapy.
Results In the initial data set of 573 patients, prognostically significant clusters representing patterns of oncogenic pathway activation and tumor biology/microenvironment states were identified within the low-risk (log-rank P = .004), intermediate-risk (log-rank P = .01), and high-risk (log-rank P = .003) model cohorts, representing clinically important genomic subphenotypes of breast cancer. As an example, in the low-risk cohort, of 6 prognostically significant clusters, patients in cluster 4 had an inferior relapse-free survival vs patients in cluster 1 (log-rank P = .004) and cluster 5 (log-rank P = .03). Median relapse-free survival for patients in cluster 4 was 16 months less than for patients in cluster 1 (95% CI, 7.5-24.5 months) and 19 months less than for patients in cluster 5 (95% CI, 10.5-27.5 months). Multivariate analyses confirmed the independent prognostic value of the genomic clusters (low risk, P = .05; high risk, P = .02). The reproducibility and validity of these patterns of pathway deregulation in predicting relapse risk was established using related but not identical clusters in the independent validation cohort. The prognostic clinicogenomic clusters also have unique sensitivity patterns to commonly used cytotoxic therapies.
Conclusions These results provide preliminary evidence that incorporation of gene expression signatures into clinical risk stratification can refine prognosis. Prospective studies are needed to determine the value of this approach for individualizing therapeutic strategies.